FDA busts Concordia on phone marketing violation; Lundbeck launches Selincro in Spain;

> A professional telephone script used by Concordia Pharmaceuticals to market its extended-released Kapvay tablets has violated the FDA's advertising regulations, the agency says. More

> Lundbeck has launched alcohol dependence med Selincro in Spain. Release

> Merck ($MRK) and the Positive Women's Network have teamed up for national HIV campaign "I Design." Story

> Quintiles ($Q) will commercialize Basilea Pharmaceutica's antibiotic Zevtera/Mabelio in Europe. Report

> Galena Biopharma has licensed the U.S. rights for oral soluble film Zuplenz. Release

> Arena Pharma ($ARNA) and Teva ($TEVA) have inked a marketing and supply deal for obesity drug Belviq in Israel. More

> Anacor Pharmaceuticals ($ANAC) and Novartis' ($NVS) Sandoz have entered a commercialization agreement for topical solution Kerydin in the United States. Release

And Finally... Eisai has launched Chocola BB Royal Drink, designed to promote beauty and wellness, in China. More

Suggested Articles

Amgen could soon face new competition in the PCSK9 class, but an efficacy boost in treating high-risk heart attack patients could help keep it ahead.

Having already whiffed on one crucial heart failure trial, Novartis is focusing on "profound" data from its Entresto studies in hopes for another go.

Bristol-Myers Squibb and Pfizer's Eliqus has taken the U.S. warfarin alternative market by storm, but can afib screening amp it up even more?